Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Schizophrenia Research
Journal
Overview
Identity
Overview
Publication Venue For
A comparison of stages of attention for social and nonsocial stimuli in schizophrenia: An ERP study
. 238:128-136.
2021
Abnormalities in the copper transporter CTR1 in postmortem hippocampus in schizophrenia: A subregion and laminar analysis
. 228:60-73.
2021
Markers of copper transport in the cingulum bundle in schizophrenia
. 228:124-133.
2021
Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studies
. 223:29-42.
2020
Relationship of poor insight to neurocognition, social cognition, and psychiatric symptoms in schizophrenia: A meta-analysis
. 220:164-171.
2020
Associations between physiological responses to social-evaluative stress and daily functioning in first-episode schizophrenia
. 218:233-239.
2020
AMPA receptor subunit localization in schizophrenia anterior cingulate cortex
2020
The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders – A systematic review of magnetic resonance spectroscopy studies
2020
Ultrastructural evidence for glutamatergic dysregulation in schizophrenia
2020
A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia
. 210:239-244.
2019
The transcriptome landscape associated with Disrupted-in-Schizophrenia-1 locus impairment in early development and adulthood
. 210:149-156.
2019
N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study
. 208:479-480.
2019
Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia
. 204:262-270.
2019
Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia
. 204:104-110.
2019
Cognitive remediation can improve negative symptoms and social functioning in first-episode schizophrenia: A randomized controlled trial
. 203:24-31.
2019
Abnormal expression of ER quality control and ER associated degradation proteins in the dorsolateral prefrontal cortex in schizophrenia
. 197:484-491.
2018
Substantia nigra ultrastructural pathology in schizophrenia
. 197:209-218.
2018
Translocator protein (TSPO) and stress cascades in mouse models of psychosis with inflammatory disturbances
. 197:492-497.
2018
The effects of curcumin on brain-derived neurotrophic factor and cognition in schizophrenia: A randomized controlled study
. 195:572-573.
2018
Linking optic radiation volume to visual perception in schizophrenia and bipolar disorder
. 190:102-106.
2017
Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia
. 182:66-73.
2017
Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia
. 177:78-87.
2016
Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing
. 176:467-472.
2016
Modulation of neurophysiological auditory processing measures by bilateral transcranial direct current stimulation in schizophrenia
. 174:189-191.
2016
Cognitive Assessment Interview (CAI): Validity as a co-primary measure of cognition across phases of schizophrenia
. 172:137-142.
2016
A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia
. 170:341-350.
2016
Uncovering the role of the nucleus accumbens in schizophrenia: A postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters
. 169:369-373.
2015
Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia
. 168:543-553.
2015
The effect of transcranial direct current stimulation on social cognition in schizophrenia: A preliminary study
. 165:171-174.
2015
UPSA-M: Feasibility and initial validity of a mobile application of the UCSD Performance-Based Skills Assessment
. 164:187-192.
2015
Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia
. 166:219-224.
2015
Factor structure and heritability of endophenotypes in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS-1)
. 163:73-79.
2015
Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) Study: The moderating role of smoking status and antipsychotic medications
. 163:24-31.
2015
Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8years later
. 161:407-413.
2015
Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia
. 159:130-135.
2014
The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia
. 159:95-100.
2014
Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia
. 154:1-13.
2014
Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophrenia
. 154:36-41.
2014
Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment
. 157:33-39.
2014
Evidence of allelic imbalance in the schizophrenia susceptibility gene ZNF804A in human dorsolateral prefrontal cortex
. 152:111-116.
2014
Neurocognition and symptoms identify links between facial recognition and emotion processing in schizophrenia: Meta-analytic findings
. 151:78-84.
2013
Effects of single dose intranasal oxytocin on social cognition in schizophrenia
. 147:393-397.
2013
Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia
. 147:348-354.
2013
Transmembrane AMPA receptor regulatory protein (TARP) dysregulation in anterior cingulate cortex in schizophrenia
. 147:32-38.
2013
Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia
. 146:177-183.
2013
Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia
. 144:1-8.
2013
Cognitive training at home in schizophrenia is feasible
. 143:397-398.
2013
Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging
. 140:136-142.
2012
Factor structure of emotional intelligence in schizophrenia
. 139:78-81.
2012
Heritability of functioning in families with schizophrenia in relation to neurocognition
. 139:105-109.
2012
Regional differences in expression of β-tubulin isoforms in schizophrenia
. 135:181-186.
2012
Remission and recovery during the first outpatient year of the early course of schizophrenia
. 132:18-23.
2011
Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population
. 131:52-57.
2011
Endosomal trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia
. 130:260-265.
2011
Do patients with schizophrenia benefit from a self-referential memory bias?
. 127:171-177.
2011
Relationships between perceptions of the family environment and of negative life events in recent-onset schizophrenia patients
. 127:266-267.
2011
Disorganization and reality distortion in schizophrenia: A meta-analysis of the relationship between positive symptoms and neurocognitive deficits
. 121:1-14.
2010
Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia
. 119:198-209.
2010
Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia
. 117:92-98.
2010
Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder
. 114:50-56.
2009
Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: A meta-analysis
. 113:189-199.
2009
Linkage analysis of schizophrenia in African-American families
. 109:70-79.
2009
Emotional intelligence in schizophrenia
. 107:61-68.
2009
Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia
. 104:108-120.
2008
Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia
. 103:71-82.
2008
Stability of visual masking performance in recent-onset schizophrenia: An 18-month longitudinal study
. 103:266-274.
2008
Diffusion tensor imaging in schizophrenia: Relationship to symptoms
. 98:157-162.
2008
Visual self-recognition in patients with schizophrenia
. 94:215-220.
2007
Disruption of hippocampal connectivity in children and adolescents with schizophrenia - A voxel-based diffusion tensor imaging study
. 90:302-307.
2007
Erratum to "Project among African-Americans to explore risks for schizophrenia (PAARTNERS): Recruitment and assessment methods" [Schizophrenia Research 87 (1-3) (2006) 32-44] (DOI:10.1016/j.schres.2006.06.027)
. 90:369.
2007
Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia
. 90:15-27.
2007
Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia
. 86:167-171.
2006
The role of stimulus salience in CPT-AX performance of schizophrenia patients
. 81:191-197.
2006
Project among African-Americans to explore risks for schizophrenia (PAARTNERS): Recruitment and assessment methods
. 87:32-44.
2006
Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression
. 78:87-93.
2005
Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia
. 75:27-34.
2005
NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder
. 71:361-370.
2004
Thalamic dysfunction in schizophrenia: Neurochemical, neuropathological, and in vivo imaging abnormalities
. 69:237-253.
2004
Neurocognitive measures of prefrontal cortical dysfunction in schizophrenia
. 68:65-73.
2004
Dopamine-induced oxidative stress in neurons with glutathione deficit: Implication for schizophrenia
. 62:213-224.
2003
Effects of clozapine and haloperidol on 5-HT
6
receptor mRNA levels in rat brain
. 38:7-12.
1999
Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders
. 33:113-118.
1998
The relationship between smooth pursuit eye movements and tardive dyskinesia in schizophrenia
. 31:141-150.
1998
Clozapine-reserpine combination for refractory psychosis
. 25:259-260.
1997
Smoking, smoking withdrawal and schizophrenia: Case reports and a review of the literature
. 22:133-141.
1996
Identity
International Standard Serial Number (issn)
0920-9964
Electronic International Standard Serial Number (eissn)
1573-2509